{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:41:39Z","timestamp":1778024499889,"version":"3.51.4"},"reference-count":33,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024073","name":"Dr. Willmar Schwabe GmbH & Co. KG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024073","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background Menthacarin was shown to be effective and safe in clinical trials in patients with functional dyspepsia (FD). Long-term treatment results have not been reported yet.<\/jats:p>\n                  <jats:p>Methods An open-label, 11-month follow-up (FU) was offered to FD patients who had undergone treatment with Menthacarin (1 gastro-resistant capsule b.i.d. vs. placebo (PL)) in a 4-week, double-blind, clinical trial. During FU, all patients (former verum and PL) were treated with 1 gastro-resistant capsule Menthacarin b.i.d. Main outcomes were the changes in pain intensity and severity of sensation of pressure, heaviness, and fullness from original baseline and global improvement.<\/jats:p>\n                  <jats:p>Results 70 patients were included in the analyses (former Menthacarin group: 36, former PL group: 34). At the end of the PL-controlled study phase, all 3 main efficacy variables were statistically significantly improved in the Menthacarin group compared to PL. In the FU phase, former PL patients started to improve under Menthacarin treatment towards the outcomes seen in the former Menthacarin group (alignment at approximately 6 months), while former Menthacarin patients showed sustained or even continuously improved outcomes by month 12. At study end, more than 90% of patients were \u201cmuch or very much improved\" in both groups. Menthacarin treatment was well tolerated.<\/jats:p>\n                  <jats:p>Conclusions The favorable effects seen in the FU period suggest that Menthacarin is a valuable treatment option in FD patients who require symptomatic treatment also in the longer term for up to 12 months.<\/jats:p>","DOI":"10.1055\/a-1823-1333","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T19:10:28Z","timestamp":1655147428000},"page":"257-267","source":"Crossref","is-referenced-by-count":6,"title":["Menthacarin for long-term treatment of functional dyspepsia \u2013 Results from a clinical trial follow-up"],"prefix":"10.1055","volume":"61","author":[{"given":"Martin","family":"Storr","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Endoskopie, Starnberg, Germany und Medizinische Klinik und Poliklinik II, Klinikum Gro\u00dfhadern, M\u00fcnchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berenike","family":"Stracke","sequence":"additional","affiliation":[{"name":"Global Medical Affairs, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG Clinical Guideline: Management of Dyspepsia","volume":"112","author":"PM Moayyedi","year":"2017","journal-title":"American Journal of Gastroenterology"},{"issue":"S 02","key":"ref2","doi-asserted-by":"publisher","first-page":"Ii37","DOI":"10.1136\/gut.45.2008.ii37","article-title":"Functional gastroduodenal disorders","volume":"45","author":"NJ Talley","year":"1999","journal-title":"Gut"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV","author":"DA Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/apt.12865","article-title":"Review article: adherence to Rome criteria in therapeutic trials in functional dyspepsia","volume":"40","author":"V Stanghellini","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal Disorders","volume":"150","author":"V Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000485408","article-title":"Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV","volume":"35","author":"V Stanghellini","year":"2017","journal-title":"Dig Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/s0140-6736(20)30469-4","article-title":"Functional dyspepsia","volume":"396","author":"AC Ford","year":"2020","journal-title":"The Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/s2468-1253(18)30003-7","article-title":"Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study","volume":"3","author":"I Aziz","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3238\/arztebl.2018.0222","article-title":"The Diagnosis and Treatment of Functional Dyspepsia","volume":"115","author":"A Madisch","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.3748\/wjg.v11.i42.6577","article-title":"Management of functional dyspepsia: Unsolved problems and new perspectives","volume":"11","author":"A Madisch","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s10354-017-0557-3","article-title":"Modulation of gastrointestinal motility beyond metoclopramide and domperidone: Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders","volume":"167","author":"A Madisch","year":"2017","journal-title":"Wien Med Wochenschr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/mog.0000000000000306","article-title":"Functional dyspepsia","volume":"32","author":"NJ Talley","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"key":"ref13","first-page":"1149","article-title":"Efficacy of a fixed peppermint oil\/caraway oil combination in non-ulcer dyspepsia","volume":"46","author":"B May","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1055\/s-0031-1300528","article-title":"Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study","volume":"49","author":"A Madisch","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1046\/j.1365-2036.2000.00873.x","article-title":"Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia","volume":"14","author":"B May","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"ref16","first-page":"210","article-title":"Pfefferminz\u00f6l\/K\u00fcmmel\u00f6l-Fixkombination bei nicht-s\u00e4urebedingter Dyspepsie-Vergleich der Wirksamkeit und Vertr\u00e4glichkeit zweier galenischer Zubereitungen","volume":"54","author":"J Freise","year":"1999","journal-title":"Pharmazie"},{"issue":"11","key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13132","article-title":"A randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia","volume":"29","author":"G Rich","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0016-5085(91)90459-x","article-title":"The mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig","volume":"101","author":"JM Hills","year":"1991","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/s0140-6736(82)90191-x","article-title":"Peppermint oil to reduce colonic spasm during endoscopy","volume":"2","author":"RJ Leicester","year":"1982","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ptr.1089","article-title":"Effects of intraduodenal application of peppermint oil (WS 1340) and caraway oil (WS 1520) on gastroduodenal motility in healthy volunteers","volume":"17","author":"G Micklefield","year":"2003","journal-title":"Phytother Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/(sici)1099-1573(200002)14:1<20::aid-ptr542>3.0.co;2-z","article-title":"Effects of peppermint oil and caraway oil on gastroduodenal motility","volume":"14","author":"GH Micklefield","year":"2000","journal-title":"Phytother Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ejphar.2014.07.018","article-title":"Effects of menthol on circular smooth muscle of human colon: analysis of the mechanism of action","volume":"740","author":"A Amato","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e13748","DOI":"10.1111\/nmo.13748","article-title":"Peppermint and caraway oils have muscle inhibitory and pro-secretory activity in the human intestine in vitro","volume":"32","author":"D Krueger","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1751-2980.2011.00513.x","article-title":"Preliminary experimental research on the mechanism of liver bile secretion stimulated by peppermint oil","volume":"12","author":"L Zong","year":"2011","journal-title":"J Dig Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.pain.2011.11.014","article-title":"Menthol pain relief through cumulative inactivation of voltage-gated sodium channels","volume":"153","author":"C Gaudioso","year":"2012","journal-title":"Pain"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/ptr.3316","article-title":"Mode of action of peppermint oil and (-)-menthol with respect to 5-HT3 receptor subtypes: binding studies, cation uptake by receptor channels and contraction of isolated rat ileum","volume":"25","author":"K Heimes","year":"2011","journal-title":"Phytother Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.pain.2011.01.027","article-title":"A novel role for TRPM8 in visceral afferent function","volume":"152","author":"AM Harrington","year":"2011","journal-title":"Pain"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1046\/j.1365-2036.2003.01522.x","article-title":"Peppermint oil and caraway oil in functional dyspepsia \u2013 efficacy unaffected by H. pylori","volume":"17","author":"B May","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"KV420","DOI":"10.1055\/s-0036-1587195","article-title":"Effects of Menthacarin on symptoms and quality of life in patients with functional dyspepsia: Result of a 8-week optional placebo controlled follow-up","volume":"54","author":"G Holtmann","year":"2016","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11096-013-9893-6","article-title":"Evidence for compliance with long-term medication: a systematic review of randomised controlled trials","volume":"36","author":"MA King","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/tcrm.s1458","article-title":"Factors affecting therapeutic compliance: A review from the patient\u2019s perspective","volume":"4","author":"J Jin","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"ref32","first-page":"28 (Z025)","article-title":"Sicherheit und Vertr\u00e4glichkeit einer Pfefferminz\u00f6l\/K\u00fcmmel\u00f6l-Kombination bei funktionellen gastrointestinalen Beschwerden \u2013 ein systematischer Review","volume":"56","author":"A Madisch","year":"2015","journal-title":"Internist (Berl)"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10354-018-0635-1","article-title":"Effectiveness of Menthacarin on symptoms of irritable bowel syndrome","volume":"169","author":"A Madisch","year":"2019","journal-title":"Wien Med Wochenschr"}],"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1823-1333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:08:00Z","timestamp":1764133680000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1823-1333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":33,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2023,3,9]]},"published-print":{"date-parts":[[2023,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1823-1333","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"value":"0044-2771","type":"print"},{"value":"1439-7803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]}}}